Correlational study of the serum levels of the glial fibrillary acidic protein and neurofilament proteins in Parkinson's disease patients
Authors:
- Wen SuWSWen Su
- Hai Bo ChenHCHai Bo Chen
- Shu Hua LiSLShu Hua Li
- Dong Ying WuDWDong Ying Wu
- 1 May 2012
- journal article
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 114 (4) , 372-375
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- CSF neurofilament proteins in the differential diagnosis of dementiaJournal of Neurology, Neurosurgery & Psychiatry, 2007
- Serum GFAP is a diagnostic marker for glioblastoma multiformeBrain, 2007
- CSF neurofilament light chain and tau differentiate multiple system atrophy from Parkinson's diseaseNeurobiology of Aging, 2007
- Serum Glial Fibrillary Acidic Protein Is Related to Focal Brain Injury and Outcome After Aneurysmal Subarachnoid HemorrhageStroke, 2007
- Serum glial fibrillary acidic protein as a biomarker for intracerebral haemorrhage in patients with acute strokeJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Presence of reactive microglia in monkey substantia nigra years after 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine administrationAnnals of Neurology, 2003
- Release of Glial Tissue–Specific Proteins After Acute StrokeStroke, 2000
- Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple‐system atrophy compared with Parkinson's diseaseMovement Disorders, 1998
- Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neuronsJournal of Comparative Neurology, 1993
- Anti-neurofilament antibodies in blood of patients with neurological diseasesActa Neuropathologica, 1986